WiCON | Pharma China (Web Edition)

Top News Worldwide

SFDA issues the No.67~ No.71 announcements of drug administrative protection 10/13/2005

The State Food and Drug Administration (SFDA) issued the No.67 Drug Administrative Protection Announcement on September 5, 2005, declaring the ending of drug administrative protection for BYK Gulden's Protonix (pantoprazole sodium).

The State Food and Drug Administration (SFDA) issued the No.68 Drug Administrative Protection Announcement on September 5, 2005, declaring the ending of drug administrative protection for BYK Gulden's Pantoloc iv (pantoprazole sodium iv).

The State Food and Drug Administration (SFDA) issued the No.69 Drug Administrative Protection Announcement on September 12, 2005, declaring the ending of drug administrative protection for Smith Kline Beecham's Famvir (famciclovir).

The State Food and Drug Administration (SFDA) issued the No.70 Drug Administrative Protection Announcement on September 12,2005, declaring the ending of drug administrative protection for Sanofi-Synthelabo France's Mizollen (mizolastine).

The State Food and Drug Administration (SFDA) issued the No.71 Drug Administrative Protection Announcement on September 19, 2005, declaring the ending of drug administrative protection for Rhone Poulenc's Sparatm(sparfloxacin).

Relate News

此页面上的内容需要较新版本的 Adobe Flash Player。